Institute for Human Genetics and Biochemistry Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2012
NCT01731691
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now